Results 141 to 150 of about 4,372,209 (230)

‘Resilient’ Refugees? Eritreans in Addis Ababa

Development and Change, EarlyView.
ABSTRACT Resilience — the ability to ‘bounce back better’ from hardships — has gained prominence as an empowering idea for refugees worldwide. However, due to its conceptual ambiguity, there is no consensus on what counts as ‘resilience’ in practice. To survive without access to humanitarian aid or the right to work, Eritrean refugees in Addis Ababa ...
Naohiko Omata
wiley   +1 more source

Picropodophyllotoxin Suppresses Factor Xa Activity, Platelet Aggregation, and Arterial Thrombosis. [PDF]

Biomolecules
Han G, Kim GE, Kim MS, Kim J, Bae JS.
europepmc   +1 more source

Venous Thromboembolism in Hematologic Malignancies: Incidence, Risk Factors, and the Role of Direct Oral Anticoagulants

European Journal of Haematology, EarlyView.
ABSTRACT Thrombotic events, particularly venous thromboembolism (VTE), are a significant source of morbidity and mortality among patients with hematologic malignancies. These patients face unique challenges due to treatment‐related complications such as thrombocytopenia, coagulopathy, and heightened bleeding risk.
Mario Biglietto, Silvia Sorella, Erminia Baldacci, Massimo Breccia, Sabina Chiaretti, Marcello Capriata, Livia Donzelli, Gianna Maria D'Elia, Salvatore Giacomo Morano, Ilaria Del Giudice, Maurizio Martelli, Cristina Santoro, Antonio Chistolini   +12 more
wiley   +1 more source

Repeated intra‐operative heparin dosing for cardiopulmonary bypass and the PRODOSE algorithm

Anaesthesia, EarlyView.
Stanislaw Vander Zwaag, Jens Fassl, Michaël Vandenheuvel, Lachlan F. Miles   +3 more
wiley   +1 more source

Climate Regulation and ESG Disclosure in Maritime Transport

European Financial Management, EarlyView.
ABSTRACT This paper investigates whether climate policy signals influence ESG disclosure quality in maritime transport, a capital‐intensive industry responsible for roughly 3% of global CO₂ emissions. Using panel data from 126 listed shipping firms between 2009 and 2023, we construct an author‐based disclosure quality index and treat the IMO's 2018 ...
Xakousti Afroditi Merika, Theodore Syriopoulos   +1 more
wiley   +1 more source

Subsequent Thromboembolic and Bleeding Events in Patients With Major Bleeding While on Factor Xa Inhibitors. [PDF]

Circ Rep
Suzuki T, Yasaka M, Wada F, Ide R, Suzuki K, Kohsaka S.   +5 more
europepmc   +1 more source

The tryptophan prenyltransferase ComQ from Bacillus subtilis 168 can prenylate daptomycin at Trp1

The FEBS Journal, EarlyView.
ComQ168 from Bacillus subtilis 168 catalyzes C‐terminal tryptophan farnesylation of ComX to generate a competence‐inducing pheromone. Recombinant ComQ168 also modifies cyclic peptides, including Daptomycin, likely at the N‐terminal tryptophan. Structural modeling highlights a C‐terminal binding region, supporting substrate promiscuity and establishing ...
Yanli Xu, Maximilian J. L. J. Fürst, Oscar P. Kuipers   +2 more
wiley   +1 more source

Thromboembolic risk and factor Xa inhibitor use in nephrotic syndrome: a pilot study in a predominantly Hispanic cohort. [PDF]

Clin Kidney J
Fernando PC, Crestani A, Subrata D, Lorenzo C, Nassar T, Kanduri SR.   +5 more
europepmc   +1 more source

Toward a minimal amino acid alphabet for protein design

The FEBS Journal, EarlyView.
Proteins are built from 20 canonical amino acids; however, it is interesting to investigate whether they can also be formed from reduced amino acid alphabets. Using protein design, we designed proteins based on all alphabets comprising 2 to 10 ‘early’ amino acids (those likely to have been present before the origin of life).
Karel Půbal, Kseniia Kushnir, Vojtěch Spiwok, Karolína Loužecká, Vladimír Setnička, Petra Lipovová   +5 more
wiley   +1 more source

Safety Pharmacology, Toxicokinetics and Pharmacodynamics of VMX-C001, an Intravenous Bypassing Agent for Factor Xa Inhibitors, in Animal Models. [PDF]

Pharmaceutics
Verhoef D, Short G, Gomes T, Groen K, Spronk H, Ohrstrom J, Reitsma PH.   +6 more
europepmc   +1 more source